| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Marketing Teams; Do Not Just Participate Dominate |
|
Just Other Articles - Marketing Teams; Do Not Just Participate Dominate
So many marketing teams claim to be the life blood of a business and s According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ometimes they are and yet so many times I see that marketing teams fai ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in companies miserably. But why you ask? Well too many know-it-alls tryi lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ng to do the same old thing and running redline against the competitio here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe , which is also doing the same old thing and you have to wonder why? W d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ell, because this is the way we always do it and this way works? Does ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t now? Indeed and I suppose this is why you stock is tanked and same s easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tore sales are down too? Good going Marketing Team! Rah! Well, the fa nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically t is that most marketing teams cannot market their companies out of a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ paper bag. Paper or Plastic actually and I am not attacking the Indust ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi y Association, Status Quo or the Pillars of Academia individually, I a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a attacking all of them at once and simply saying that our marketing te dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ams could blow them out of the water. Silly humans running marketing t cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ams, get a life or rather get a job? I have a motto for Marketing Team tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s; Do Not Just Participate Dominate. Look I only care about winning. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel inning market share, increasing profits and opening the flood gates of ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust customers who await. I want them lined up to buy my products and or s y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products rvices not my competitions. So, really all the talk and hoopla is bogu . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s BS, either you are the lead dog or the view and the smell never chan elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip es. So please consider all this in 2006 if you are on a marketing team tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Avoid Implementation Failure Managing Between The Process and The Output
|